Last week, Naomi Elster, a scientist researching for a PhD in cancer medicine at the Royal College of Surgeons, published a three-part series on the origin, evolution and future of chemotherapy in the Guardian newspaper.
The articles provide a good introduction to the concept of targeted drugs and how researchers are investigating drug resistance. The conclusion looks toward a challenging future for cancer research. Read more here.
No comments:
Post a Comment